Menu

Genetic Analysis Reveals the Evolutionary History of Dogs

By analyzing the genomes of 161 dog breeds, scientists discover how and when certain canine breeds emerged.

Apr 26, 2017
Diana Kwon

PIXABAY, KATRINBECHTEL

Domestic dogs (Canis familiaris) have lived alongside humans for thousands of years. An extensive genetic analysis, published this week (April 25) in Cell Reports, now sheds light on the roles that factors like migration and breeding likely played in canine evolution.

“Each time we come up with different changes into our own sort of society and the way we live, then there’s room for a new kind of dog, or a new shape, a new size,” coauthor Heidi Parker, a dog geneticist at the US National Institutes of Health, told The Verge.

Park and colleagues assessed the genomes of 1,346 dogs across 161 breeds to assemble an extensive family tree, outlining the canines’ evolutionary histories. The team’s analysis revealed that the 161 dog breeds fell into 23 genetically defined groups, or clades. By assessing these clades, the researchers discovered that certain traits, such as herding, were bred for multiple times across history. They also found evidence that certain dogs were used to develop specific traits—pug genes, for example, emerged across a number of small dog genomes. Signs of cross-breeding after human migration, such as German shepherd genes in the Peruvian hairless dog (a New World canine), also appeared in some dogs’ genomes.

“They show that by using genetics, you can really show what was going on as [breeders] were making these breeds,” Elinor Karlsson, a computational biologist at the University of Massachusetts Medical Center who was not involved with the work, told Science. “The whole period in between [domestication and today] has been a black box.”

The new canine family tree could help veterinarians spot genetic risk factors for disease, Parker told Science.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.